Adaptimmune Therapeutics plc (ADAP) Social Stream



Adaptimmune Therapeutics plc (ADAP): $1.66

0.19 (+13.05%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ADAP to Watchlist
Sign Up

Industry: Biotech


Ranked

of 392

in industry

Featured Post From StockTwits About ADAP

$ADAP New SEC Filing: 8-K Material Agrmt - Adaptimmune Therapeutics PLC (0001621227) August 13


Item 1.01. Entry into a Material Definitive Agreement. On August 13, 2021, Adaptimmune Therapeutics plc (the "Company" or "Adaptimmune") entered into an agreement with MEPC Milton Park No. 1 Limited and MEPC Milton Park No. 2 Limited ("MEPC") relating to variations of leases of 39 Innovation Drive and 60 Jubilee Avenue, Milton Park, Oxfordshire, U.K. (the "Agreement"). Pursuant to the Agreement, on August 13, 2021, MEPC issued a letter to Barclays Bank PLC (the "Bank") to instruct the cancellation of the guarantee in favor of MEPC relating to the lease of 60 Jubilee Avenue (the "Bank Guarantee") and the Company entered into a Deed of Variation with MEPC relating to the lease of that property (...)

https://mkn.re/97301
MarketNewswire, published August 13, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4214 seconds.